| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10016007 | HBV | ENSG00000164344.17 | protein_coding | KLKB1 | No | No | 3818 | E9PBC5 P03952 |
| TVIS10029862 | HBV | ENSG00000164344.17 | protein_coding | KLKB1 | No | No | 3818 | E9PBC5 P03952 |
| TVIS30077936 | HIV | ENSG00000164344.17 | protein_coding | KLKB1 | No | No | 3818 | E9PBC5 P03952 |
| TVIS20026118 | HPV | ENSG00000164344.17 | protein_coding | KLKB1 | No | No | 3818 | E9PBC5 P03952 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | KLKB1 |
|---|---|
| DrugBank ID | DB05311 |
| Drug Name | Ecallantide |
| Target ID | BE0002440 |
| UniProt ID | P03952 |
| Regulation Type | inhibitor |
| PubMed IDs | 18613770 |
| Citations | Lehmann A: Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery. Expert Opin Biol Ther. 2008 Aug;8(8):1187-99. doi: 10.1517/14712598.8.8.1187 . |
| Groups | Approved; Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL1201837 |
